Already at best price
MSN Sita 25mg Tablet
Sitagliptin (25mg)
MSN Laboratories
Anti-Diabetic
₹60.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹60.00
Active composition
Sitagliptin 25 mg
How It Works
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medicine Strength
25 mg
Uses & Benefits
Medical applications
Diabetes
The MSN Sita 25mg Tablet is a pharmaceutical preparation containing Sitagliptin as its active ingredient, with a potency of 25mg per tablet. This medication, classified within the oral hypoglycemic agents, is primarily indicated for the treatment of Type 2 Diabetes Mellitus in adults. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, helps to stimulate the release of insulin and suppress the production of glucagon, thereby reducing blood sugar levels. It is essential to follow the prescribed dosage and duration, and maintain regular monitoring of blood glucose levels during treatment. Consult a healthcare professional for proper guidance on the use of MSN Sita 25mg Tablet, and to ensure its safe and effective administration in managing Type 2 Diabetes Mellitus.
Dosage & How to Use
Pyrazine-derivative
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of MSN Sita 25mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
MSN Sita 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
MSN Sita 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of MSN Sita 25mg Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
MSN Sita 25mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of MSN Sita 25mg Tablet may not be needed in these patients. Please consult your doctor. However, MSN Sita 25mg Tablet has not been studied in patients with severe hepatic impairment and is not recommended for use in such patients.
Regular Checkup
Customer Reviews
0 reviews for MSN Sita 25mg Tablet
MSN Sita 25mg Tablet
1 / 3
MSN Sita 25mg Tablet
Sitagliptin (25mg)
₹60.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Sitagliptin 25 mg
How It Works
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medicine Strength
25 mg
Uses & Benefits
Medical applications
Diabetes
The MSN Sita 25mg Tablet is a pharmaceutical preparation containing Sitagliptin as its active ingredient, with a potency of 25mg per tablet. This medication, classified within the oral hypoglycemic agents, is primarily indicated for the treatment of Type 2 Diabetes Mellitus in adults. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, helps to stimulate the release of insulin and suppress the production of glucagon, thereby reducing blood sugar levels. It is essential to follow the prescribed dosage and duration, and maintain regular monitoring of blood glucose levels during treatment. Consult a healthcare professional for proper guidance on the use of MSN Sita 25mg Tablet, and to ensure its safe and effective administration in managing Type 2 Diabetes Mellitus.
Dosage & How to Use
Pyrazine-derivative
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of MSN Sita 25mg Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
MSN Sita 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
MSN Sita 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of MSN Sita 25mg Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
MSN Sita 25mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of MSN Sita 25mg Tablet may not be needed in these patients. Please consult your doctor. However, MSN Sita 25mg Tablet has not been studied in patients with severe hepatic impairment and is not recommended for use in such patients.
Regular Checkup
Customer Reviews
0 reviews for MSN Sita 25mg Tablet
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)